3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Leukemia
10
Burkitt Lymphoma
9
Recurrence
8
Lymphoproliferative Disorders
6
Lymphoma, Non-Hodgkin
5
Lymphatic Diseases
5
Immunoproliferative Disorders
4
Neoplasms
3
Neoplasm, Residual
3
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma
2
Leukemia, Lymphoid
2
Neoplasms by Histologic Type
1
Myelodysplastic Syndromes
1
Lymphoma, B-Cell
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Large Granular Lymphocytic
1
Leukemia, Biphenotypic, Acute
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Bites and Stings
1
Interventions
rozanolixizumab
5
zilucoplan
4
eculizumab
4
efgartigimod alfa
3
Rituximab
2
Prednisone
2
Amifampridine
2
thymoglobulin
1
satralizumab
1
rhoA GTP-Binding Protein
1
ravulizumab
1
iscalimab
1
inebilizumab
1
gamma-Globulins
1
Thymectomy
1
Sugars
1
Steroids
1
Sodium Chloride
1
Robotic Surgical Procedures
1
Prednisolone
1
Methylprednisolone
1
Methotrexate
1
Mesna
1
Hizentra
1
Hematopoietic Stem Cell Transplantation
1
Granulocyte Colony-Stimulating Factor
1
Fluid Therapy
1
Cyclophosphamide
1
Acupuncture Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Myasthenia Gravis
×
blinatumomab
×
Clear all
No trials found.